World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
97777
World Ranking
4250
National Ranking
164

Overview

Rafael Diaz is affiliated with the University of Alberta in Canada. Their research primarily intersects the field of Medicine with a focus on Cardiology and Cardiovascular Medicine, Surgery, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, and Public Health, Environmental and Occupational Health.

The scientist's main research topics cover areas related to Lipoproteins and Cardiovascular Health, Heart Failure Treatment and Management, Health Systems including Economic Evaluations and Quality of Life, Antiplatelet Therapy and Cardiovascular Diseases, Cardiovascular Function and Risk Factors, Pharmaceutical Economics and Policy, and the intersection of Diabetes, Cardiovascular Risks, and Lipoproteins.

Frequent publication venues for Rafael Diaz include:

  • Journal of the American College of Cardiology
  • Circulation
  • European Heart Journal
  • European Journal of Heart Failure
  • Diabetes Care

Frequent co-authors collaborating with Diaz comprise:

  • Deepak L. Bhatt
  • Philippe Gabríel Steg
  • Michael Szarek
  • J. Wouter Jukema
  • Vera Bittner

Selected recent papers authored or co-authored by Rafael Diaz include:

  • "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease," 2020, New England Journal of Medicine
  • "Rivaroxaban in Peripheral Artery Disease after Revascularization," 2020, New England Journal of Medicine
  • "Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial," 2022, The Lancet
  • "Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome," 2020, Journal of the American College of Cardiology
  • "Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study," 2020, The Lancet

Best Publications

  • Dabigatran versus warfarin in patients with atrial fibrillation

    Stuart J. Connolly;Michael D. Ezekowitz;John Eikelboom;Jonas Oldgren

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • Apixaban in Patients with Atrial Fibrillation

    Stuart J. Connolly;John Eikelboom;Campbell Joyner;Hans-Christoph Diener

  • Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries

    Clara K. Chow;Clara K. Chow;Koon K. Teo;Sumathy Rangarajan;Shofiqul Islam

  • Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

    Martin J O'Donnell;Martin J O'Donnell;Siu Lim Chin;Sumathy Rangarajan;Denis Xavier

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

    Salim Yusuf;Philip Joseph;Sumathy Rangarajan;Shofiqul Islam

  • Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study

    Koon K Teo;Stephanie Ounpuu;Steven Hawken;Pandey

  • ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

    D Hunt;J Varigos;F Dienstl;P Lechleitner

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Risk factors for myocardial infarction in women and men: insights from the INTERHEART study

    Sonia S. Anand;Sonia S. Anand;Sonia S. Anand;Shofiqul Islam;Shofiqul Islam;Shofiqul Islam;Annika Rosengren;Maria Grazia Franzosi

  • Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

    Mahshid Dehghan;Andrew Mente;Andrew Mente;Xiaohe Zhang;Sumathi Swaminathan

  • The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study

    Scott A Lear;Weihong Hu;Sumathy Rangarajan;Danijela Gasevic

  • Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

    Salim Yusuf;Shofiqul Islam;Clara K Chow;Sumathy Rangarajan

  • ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

    R Collins;R Peto;M Flather;S Parish

  • Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

    Salim Yusuf;Sumathy Rangarajan;Koon Teo;Shofiqul Islam

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Alvaro Avezum
Alvaro Avezum Population Health Research Institute
Patricio López-Jaramillo
Patricio López-Jaramillo University of Santander
Harvey D. White
Harvey D. White Auckland City Hospital
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Koon K. Teo
Koon K. Teo McMaster University
Annika Rosengren
Annika Rosengren Sahlgrenska University Hospital
Gilles R. Dagenais
Gilles R. Dagenais Université Laval
Shaun G. Goodman
Shaun G. Goodman University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t always mean attending medical school. There are a range of online degree programs designed for those seeking flexibility or exploring related healthcare roles. For registered nurses looking to advance, adn to np tracks provide a direct path to becoming a nurse practitioner, with bridge programs tailored for working professionals.

Nutrition is another key allied health field. The best online nutrition programs equip students to work in clinical, community, or research roles promoting health through diet.

If you’re interested in healthcare leadership, consider top online mha programs that are cahme accredited. These accredited Master of Healthcare Administration degrees prepare graduates for management positions in hospitals and health systems.

For registered nurses wanting to further their education without in-person requirements, there are online rn-bsn programs without clinicals. These programs let RNs earn a bachelor’s degree online, broadening their opportunities in the field.

Best Scientists Citing Rafael Diaz

Trending Scientists

Recently Published Articles